Thursday, 18 June 2026 04:15 PM
Advertorial
A self-pay GLP-1 telehealth review of RxSpan MD - compounded semaglutide from a brand-stated $249/month and tirzepatide from $329, how the platform-provider-pharmacy model works, what the FDA's 2026 compounding changes mean for buyers, and the verification checklist to run before you enroll.
BEVERLY HILLS, CA / ACCESS Newswire / June 18, 2026 / Quick heads-up before you dive in: this is sponsored, affiliate content made for consumer education, not an independent clinical review - and if you buy through a link here, a commission may be earned at no extra cost to you. Nothing below is medical advice. Two facts worth knowing up front: a prescription is never guaranteed (a licensed provider makes that call), and compounded medications aren't FDA-approved. The complete medical, affiliate, pricing, regulatory, and trademark disclosures are at the end.
RxSpan MD 2026 Research: Compounded Semaglutide and Tirzepatide Pricing, Physician-Guided GLP-1 Telehealth, and What to Verify Before Enrollment
View current RxSpan MD plan information on the official page
If you've been comparing GLP-1 telehealth programs, you already know the hard part isn't finding one - it's sorting out which are legit, what you'll actually pay, and whether the compounded semaglutide and tirzepatide everyone's advertising are even the same thing as Ozempic or Wegovy. This guide takes RxSpan MD through exactly that lens: what's verifiable, what's brand-stated, and what's worth confirming before you spend a dollar. No hype, no fear - just what you need to decide whether it's your match.
A quick note on the title: phrases like "Physician-Guided" and "No Hidden Fees" are RxSpan MD's own marketing language, included so readers arriving from an ad know they're in the right place. They're brand-stated, not independent guarantees of approval, pricing, results, or safety, and "What to Verify" points to the buyer checklist in this article rather than to any lab testing performed by this publication.
Last Updated: June 2026. This consumer guide draws on RxSpan MD's published website, Terms of Service, Notice of Privacy Practices, and Telehealth Medical Consent, along with FDA guidance on compounded GLP-1 medications current as of June 2026. Pricing, availability, eligibility, and regulatory status can change; confirm current details on the official RxSpan MD website before enrolling.
TL;DR: RxSpan MD is a direct-to-consumer telehealth platform that connects adults with licensed healthcare providers for prescription treatment options, including weight-loss services that may involve compounded semaglutide or compounded tirzepatide if prescribed. According to the brand's published Terms, healthcare providers using the platform are independent medical professionals responsible for the medical care they provide, and medications, if prescribed, may be fulfilled by licensed pharmacies. Prescription approval is not guaranteed, and you should confirm the provider group, dispensing pharmacy, current pricing, and state availability directly with RxSpan MD before enrollment.
Quick Verification Snapshot (As of June 2026):
Operator: RxSpan MD LLC, 465 N Roxbury Drive, Penthouse Suite, Beverly Hills, CA 90210 (per published Terms of Service)
Category: Direct-to-consumer telehealth; weight loss (GLP-1), longevity, and hair categories, plus additional men's and women's categories
Platform role: Per the brand's Terms, RxSpan MD connects users with licensed healthcare providers through telehealth consultations; the Terms place medical-care responsibility with those independent providers, and medications, if prescribed, may be fulfilled by licensed pharmacies
Prescribing: Determined by independent licensed healthcare providers; prescription is not guaranteed. Confirm the provider group and state licensing directly with RxSpan MD
Dispensing: Licensed pharmacies, per the Terms; compounded products are not FDA-approved. Confirm the dispensing pharmacy directly with RxSpan MD
Compounded semaglutide injection: brand-stated starting price $249 first month
Compounded tirzepatide injection: brand-stated starting price $329 first month
Contact: [email protected], 844-357-3601 (text or call)
Regulatory context: compounded GLP-1 medications are not FDA-approved; FDA guidance has tightened the availability and oversight context for compounded semaglutide and tirzepatide - verify the current pathway before enrolling
Buyer Takeaway: You're looking at a telehealth platform, not a pharmacy and not a single doctor's office. Three separate parties are involved - the platform, the licensed providers, and the pharmacy - and the prescription only happens if a provider decides it's appropriate for you. Hold onto that structure; it's the key to everything below.
RxSpan MD 2026 Fast Facts: What Every Buyer Should Know in 30 Seconds
Short on time? Here's the verifiable shape of what RxSpan MD offers, pulled from the brand's published website and policies. Every line is brand-stated unless noted, and you can confirm each one on the official site before you spend a dollar.
Brand: RxSpan MD, operated by RxSpan MD LLC
Headquarters: 465 N Roxbury Drive, Penthouse Suite, Beverly Hills, CA 90210
Founder (brand-stated): Dr. John Diaz, described as a board-certified plastic surgeon
Service model: brand-stated physician-reviewed telehealth treatment plans across weight loss, longevity, and hair
Primary weight-loss medications: compounded semaglutide and compounded tirzepatide (injectable and capsule forms)
Brand-name GLP-1 options referenced: Ozempic®, Wegovy®, Zepbound®
Compounded semaglutide injection: brand-stated $249 first month
Compounded tirzepatide injection: brand-stated $329 first month
Compounded semaglutide capsules / tirzepatide capsules: brand-stated $249 / $349 first month
Plan tiers (weight loss): brand-stated $249 monthly, $219/mo three-month, $199/mo six-month, $194/mo twelve-month
What the price includes (brand-stated): consultation, medication, supplies, shipping, and support
Administration: weekly self-administered subcutaneous injection (for injectable GLP-1)
Cancellation (brand-stated): cancel or change plans anytime - confirm the method and timing before enrolling
Eligibility: adults 18 and older (per Terms of Service)
Prescription: determined by a licensed provider; not guaranteed
Regulatory status: Compounded GLP-1 medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. FDA guidance has tightened the availability and oversight context for compounded semaglutide and tirzepatide, so verify the current pathway, provider approval process, and dispensing pharmacy before enrollment
Support: brand-stated 24/7 access with unlimited messaging and appointments
Contact: [email protected], 844-357-3601
Buyer Takeaway: The price you see at signup bundles the consult, the medication, supplies, and shipping into one number. That's convenient - and it also means you'll want to read the sections below on what's refundable and what changes once a prescription is written, because a bundled price behaves differently from an à la carte one.
View current RxSpan MD plan information on the official page
About the Promotional Language in This Article's Title
A lot of readers land here after clicking an RxSpan MD ad, so the title deliberately uses the brand's own marketing language for continuity - so you know you're in the right place. This article uses certain brand phrases for identification and consumer-search context only. These phrases should not be read as independent clinical findings, third-party endorsements, or guarantees of treatment approval, medication access, pricing, results, or safety. Here's the plain-English translation.
"Physician-Guided" / "Doctor-led Plans & Coaching" (brand-stated). Source: RxSpan MD's official website. What it does mean: the brand states that treatment plans are reviewed by licensed providers and that coaching support is included. What it does not mean: it isn't a third-party certification, and this article hasn't audited the clinical workflow or verified provider credentials independently.
"No Hidden Fees" (brand-stated). Source: RxSpan MD's official website. What it does mean: the brand states that its plan price includes consultation, medication, supplies, shipping, and support. What it does not mean: it isn't a guarantee against future price changes or dose-based pricing differences. Confirm your all-in total at checkout.
"Physician-Reviewed Treatment Plans" (brand-stated). Source: RxSpan MD's official website. What it does mean: the brand positions each plan as subject to provider review. What it does not mean: it doesn't guarantee you'll be approved - prescription approval is explicitly not guaranteed.
"Free, Expedited Delivery" and "Quality is our guarantee" (brand-stated). Marketing language, not a warranty or a clinical claim. They don't change the fact that compounded products aren't FDA-approved.
Buyer Takeaway: Marketing phrases describe positioning, not proof. When you see "physician-guided," read it as "a licensed provider is part of the process," then verify the specifics that matter to you - who that provider is, what the plan costs in full, and what happens if you're not approved.
What Is RxSpan MD? The Platform, the Providers, and the Pharmacy
RxSpan MD is a telehealth platform - and that one sentence carries more weight than it looks like, because the platform is one of three separate parties involved in getting a prescription product to your door. Keeping them straight is how you understand both the service and the rules around it.
According to RxSpan MD's published Terms of Service, the platform allows users to connect with licensed healthcare providers through telehealth consultations. The Terms also state that healthcare providers using the platform are independent medical professionals responsible for the medical care they provide. If a prescription is appropriate, medications may be fulfilled by licensed pharmacies. In plain terms: the published Terms place medical-care responsibility with the licensed providers, not with the technology platform, and the pharmacy is a separate licensed party.
Here's the three-party structure as the brand's materials describe it:
The platform - RxSpan MD (RxSpan MD LLC). A technology company that, per its Terms, connects patients with licensed clinical services and coordinates the membership, coaching, and support experience.
The licensed providers. Per the Terms, independent licensed medical professionals are responsible for the medical care they provide, including whether a prescription is appropriate. Confirm the specific provider group and that a provider is licensed in your state directly with RxSpan MD before enrollment.
The pharmacy. Per the Terms, medications, if prescribed, may be fulfilled by licensed pharmacies - a separate licensed party that prepares and dispenses on a valid prescription. Confirm the dispensing pharmacy directly with RxSpan MD.
Completing RxSpan MD's online assessment doesn't, by itself, create a doctor-patient relationship or guarantee a prescription. The brand's own checkout language is explicit: after checkout, a provider reviews your information to determine if treatment is right for you, and prescription is not guaranteed.
Buyer Takeaway: If a platform ever blurs these three roles - implying the website itself writes the prescription, or that paying equals getting medication - treat that as a flag. RxSpan MD's published language keeps them separate, which is what you want to see. Confirm the actual provider group and pharmacy before you enroll.
View current RxSpan MD plan information on the official page
How the RxSpan MD Three-Entity Model Works
Walking the sequence makes it concrete. You start on RxSpan MD's site and complete a health assessment - for weight loss, that includes a goal range (the brand lists tiers like 1 to 20 pounds, 25 to 50 pounds, and 50-plus pounds). You choose a plan and pay. Then, and only then, an independent licensed provider reviews your intake to decide whether treatment is clinically appropriate for you.
If the provider approves, the prescription routes to a licensed pharmacy, which prepares and ships the medication and supplies. If the provider doesn't approve, you don't get the medication, and what happens to your payment depends on the brand's refund terms - which you should confirm in writing before enrolling. The brand states that plans can be canceled or changed at any time and that support is available around the clock.
Buyer Takeaway: The order of operations matters for your money. You pay, then a provider decides. That's standard for the category, but it means the refund policy - specifically what's refundable before versus after a prescription is written - is one of the most important things you'll verify.
RxSpan MD Weight Loss: Compounded Semaglutide and Tirzepatide Options
Weight loss is RxSpan MD's headline category, built around GLP-1 medications. Two active ingredients anchor the lineup: semaglutide and tirzepatide. The brand offers both in compounded form and also references brand-name options.
Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GLP-1 and GIP receptor agonist, structurally distinct and often described as the newer-generation option. RxSpan MD lists both as injectables and, per its product pages, in capsule forms. The injectable versions are taken as a weekly self-administered subcutaneous injection.
Here's the part that trips people up: compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should not be described as the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Same active-ingredient family, different regulatory product. Compounded versions are prepared by a pharmacy and haven't undergone FDA review for safety, effectiveness, or quality before marketing. If you specifically want an FDA-approved finished product, that's a conversation to have with a licensed provider about brand-name options.
Buyer Takeaway: "Compounded semaglutide" and "Ozempic" are not interchangeable terms. Compounded semaglutide may be discussed by some consumers as a lower-cost GLP-1 option, but it isn't the same regulatory product and hasn't been FDA-reviewed before marketing. Know which one you actually want before checkout.
How Much Does RxSpan MD Cost? Brand-Stated Pricing for 2026
Quick Answer: RxSpan MD lists compounded semaglutide injection from a brand-stated $249 for the first month and compounded tirzepatide injection from $329, with plan tiers lowering the per-month price over longer terms. Brand-name options are referenced at much higher prices. Prescription approval is not guaranteed; confirm your final total at checkout.
The following pricing figures are brand-stated and were shown in the RxSpan MD source material reviewed for this article. Pricing, plan availability, dose structure, billing terms, and fulfillment options may change. Confirm the final total, billing cycle, cancellation terms, and any prescription-contingent charges before payment.
Compounded weight-loss medications (brand-stated first-month pricing):
Compounded semaglutide injection: $249
Compounded tirzepatide injection: $329
Compounded semaglutide capsules: $249
Compounded tirzepatide capsules: $349
Brand-name GLP-1 options referenced (brand-stated first-month pricing):
Ozempic®: $1,299
Wegovy®: $1,349
Zepbound®: $1,069
Weight-loss plan tiers (brand-stated):
Monthly: $249/mo
Three-month plan: $219/mo
Six-month plan: $199/mo
Twelve-month plan: $194/mo
The brand states each plan price includes consultation, medication, supplies, shipping, and support, and that plans are pre-paid monthly or quarterly. The brand also displays a sample "total if prescribed" figure (for example, $657 for a quarter at one tier) - a reminder that you're committing to a billing cycle, not a single dose. On fees, the brand uses "No Hidden Fees" language and folds the main cost components into the plan price; regardless of that claim, the cleanest move for any buyer is the same - confirm the all-in total at checkout, including any tax or dose-dependent components, before you authorize payment. Any comparison or "before" prices a brand shows are the brand's own reference points and may not reflect prevailing market prices.
Buyer Takeaway: The compounded tiers are where the price advantage lives; the brand-name tiers cost roughly four to five times as much because you're paying for the FDA-approved finished product. Decide which one you actually want before checkout, and confirm what becomes non-refundable once a prescription is written.
Review RxSpan MD's current pricing and plan details
Compounded vs. Brand-Name GLP-1 at RxSpan MD
This is the decision most RxSpan MD shoppers are really making, so let's be straight about the trade-offs. Brand-name semaglutide and tirzepatide are FDA-approved, manufactured under the original manufacturers' processes, and priced accordingly - often north of a thousand dollars a month. Compounded versions are prepared by a pharmacy, cost a fraction of that, and are not FDA-approved finished products.
What you gain with compounded: cost, and in some cases dose flexibility. What you give up: the FDA premarket review for safety, effectiveness, and quality that the brand-name finished product carries. The FDA has also reported adverse events tied to dosing errors with compounded GLP-1s, several involving patients measuring and self-administering incorrect amounts from multidose vials. That's a handling-and-dosing risk to discuss with your provider, not a blanket verdict on every compounded preparation.
Buyer Takeaway: Neither choice is automatically "better." It's a cost-versus-regulatory-status trade-off, and it belongs in your provider conversation - not in a box you click past. If provider-confirmed dosing instructions aren't crystal clear to you, ask before your first injection.
RxSpan MD Capsule and Microdosing GLP-1 Options: What the Brand Lists
Quick Answer: Beyond standard injectables, RxSpan MD's source material lists compounded GLP-1 in capsule form (semaglutide capsules at a brand-stated $249 and tirzepatide capsules at $349 for the first month) and references microdosing as a category. These are brand-stated options; whether any is appropriate for you is a clinical decision for the licensed provider, and the same not-FDA-approved status applies.
Capsule, or oral, GLP-1 appeals to people who'd rather not self-inject, and microdosing refers generally to lower-dose protocols some platforms position for tolerability or maintenance. Two honest notes to carry into your provider conversation. First, oral and microdosed compounded preparations carry the same regulatory status as the injectables: not FDA-approved, and not FDA-reviewed before marketing. Second, "microdosing" isn't a standardized clinical term with a single agreed protocol, so don't assume it means the same thing everywhere; ask the provider exactly what dose, schedule, and form you'd be prescribed and why.
This article makes no claim that any form works better than another. Form, dose, and protocol are clinical decisions, and your provider's guidance for your situation takes precedence over any positioning language on a product page.
Buyer Takeaway: More format options is a real convenience, but a capsule or a "microdose" label doesn't change the regulatory status or guarantee a result. Confirm exactly what you'd be prescribed, in what form, at what dose, before you enroll.
The 2026 FDA Context for Compounded GLP-1 Medications
Quick Answer: Compounded GLP-1 medications are not FDA-approved, and the regulatory context tightened sharply in 2025 and 2026. FDA has indicated that unapproved GLP-1 drugs don't undergo FDA review for safety, effectiveness, or quality before marketing, and that compounded drugs should generally be used only when an FDA-approved drug can't meet a patient's needs. Verify the current pathway before enrolling.
If you've been researching compounded GLP-1 programs for a while, you've probably noticed the ground has shifted. It has, and it's the most important context for anyone enrolling in 2026. Here's the verifiable sequence, framed so you can confirm each point yourself.
Compounded semaglutide and tirzepatide became widely available because both drugs were on the FDA's drug shortage list, which temporarily allowed pharmacies and outsourcing facilities to compound copies. That window has closed. The FDA determined the tirzepatide shortage resolved in late 2024 and the semaglutide shortage resolved in February 2025, and it set enforcement deadlines through 2025 for compounders to wind down shortage-based production. Industry groups challenged those determinations in federal court and did not secure injunctions, so the deadlines held.
It went further in 2026. The FDA signaled escalating enforcement, and on April 30, 2026, it proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list - the mechanism that governs which substances large-scale compounders may use - with a public comment period open through June 29, 2026. The FDA's stated reasoning is that there's no clinical need for outsourcing facilities to compound these drugs from bulk substances when FDA-approved versions exist. What survives is patient-specific compounding by state-licensed pharmacies (the 503A pathway), which remains legal under narrow, individualized conditions - a valid prescription for a specific patient with a documented clinical reason, not anticipated-demand mass production.
The practical takeaway for you is simple: availability can change, so confirm the licensed provider review process, the dispensing pharmacy, the prescription pathway, dosing instructions, shipping conditions, and current availability before enrollment. This article does not provide legal advice and does not determine whether any specific prescription, pharmacy, or fulfillment pathway is compliant in an individual case.
Buyer Takeaway: Ask the program directly which pharmacy fills your prescription, under which pathway, and what their plan is if compounded supply is further restricted. A program that answers cleanly is showing you its compliance. A program that dodges is telling you something too.
What the June 29, 2026 FDA Comment Deadline Means for Compounded GLP-1 Buyers
Quick Answer: June 29, 2026 is the close of the public comment period on the FDA's proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B outsourcing-facility bulks list. It does not ban anything by itself, but it signals where federal oversight of compounded GLP-1 is heading, which is why your enrollment timing and pharmacy questions matter more now than they did a year ago.
Here's why this date belongs on your radar, framed as information rather than alarm. The comment deadline is a milestone in a longer process, not a cliff where compounded GLP-1 vanishes overnight. What it does mean is that the regulatory direction is set: the shortage pathway that built this market is closed, and the bulk-compounding pathway for large outsourcing facilities is the next door the FDA has moved to shut. Patient-specific 503A compounding by state-licensed pharmacies remains available under narrow, individualized conditions.
For you, the practical implications are concrete. First, availability and sourcing can shift, so the question "which licensed pharmacy fills my prescription, and under which pathway" is the one to ask before you commit, not after. Second, if you're weighing compounded versus brand-name, the regulatory trajectory is part of that math, because an FDA-approved brand-name product isn't subject to the same compounding uncertainty. Third, any program's answer to "what happens to my plan if compounding is further restricted" tells you how prepared it is. None of this is a reason to rush a medical decision; it's a reason to verify carefully and on a clear timeline.
Buyer Takeaway: Treat the date as a prompt to verify, not a starter pistol. The buyers who do best here aren't the fastest; they're the ones who confirm the pharmacy, the pathway, and the refund terms before the regulatory picture shifts again.
What Evidence Exists for GLP-1 Medications, and What Does That Mean for RxSpan MD?
Quick Answer: RxSpan MD is a telehealth platform, not a drug, so this splits in two: the platform's job is connecting you to licensed care, and the medications it offers belong to a class with substantial published evidence behind the FDA-approved finished products. Outcomes depend on eligibility, prescribing decisions, dosing, adherence, and individual response. Individual results vary.
On the medication side, GLP-1 receptor agonists like semaglutide and tirzepatide have a robust evidence base in their FDA-approved finished forms. Large randomized trials of the approved products have reported clinically meaningful weight reduction in adults with obesity or overweight, which is why the category took off. That evidence is for the approved finished products, though - not for any given compounded preparation, which hasn't gone through the same review. Reasonable clinicians weigh that distinction differently.
On the platform side, RxSpan MD may provide access to provider-reviewed treatment options for eligible adults, but outcomes depend on clinical eligibility, prescribing decisions, medication type, dosing, adherence, lifestyle factors, and individual response. This is not a drug, and prescription medication should only be used under the guidance of a licensed healthcare provider.
Buyer Takeaway: The active ingredients have real science behind their approved versions. The platform's job is connecting you to a provider who decides if they're right for you. Neither fact guarantees your result, and anyone promising a number on the scale is overselling.
Is RxSpan MD Legit? A Consumer Verification Framework
Quick Answer: RxSpan MD publishes an identifiable operating entity, contact information, Terms of Service, a Privacy Notice, and a Telehealth Medical Consent - useful transparency markers. Still, you should verify the specific provider group, provider licensing in your state, dispensing pharmacy, pricing, refund and cancellation terms, privacy practices, and current availability before enrollment.
RxSpan MD provides several public-facing transparency markers you can use as part of your verification process. "Legit," though, is something you confirm across specific dimensions rather than take on faith. Run these checks yourself before enrolling - each is answerable from the brand's published materials or by asking support directly:
Identity: Confirm the operating entity and address (RxSpan MD LLC, Beverly Hills) and that contact channels respond.
Providers: Confirm the provider group and that a provider is licensed in your state.
Pharmacy: Confirm which licensed pharmacy fills prescriptions and whether it operates within current compounding rules.
Pricing: Confirm the all-in total, the billing cycle, and what's included.
Refunds: Confirm what's refundable before and after a prescription is written.
Cancellation: Confirm the exact method and timing to cancel or change a plan.
Privacy: Confirm how your health data is handled and ask any data-specific questions before enrolling.
The brand's site displays "Verify Approval for www.rxspanmd.com" language; treat any third-party verification badge as something to confirm at its source rather than accept on sight. This article hasn't independently audited any certification.
Buyer Takeaway: "Is it a scam" is the wrong question; "can I verify each thing that matters to me" is the right one. RxSpan MD gives you enough published information to run those checks. Do them, and you'll know far more than a star rating could ever tell you.
Check RxSpan MD's current eligibility assessment
How to Read RxSpan MD's Marketing Language
Every brand in this category leads with its strongest framing, and RxSpan MD is no exception. Reading that language accurately protects your wallet and your expectations. Here's the translation, with each phrase marked brand-stated.
"Physician-Guided" and "Doctor-led" (brand-stated). Positioning that licensed providers are part of the process. Not a guarantee of approval, and not a third-party credential audit.
"No Hidden Fees" (brand-stated). A statement that core costs are bundled into the plan price. Still confirm your all-in total at checkout.
"Free, Expedited Delivery" (brand-stated). A shipping-inclusion statement. Confirm timelines and any conditions.
"Quality is our guarantee" (brand-stated). Marketing language, not a warranty or clinical claim. It doesn't change the compounded products' non-approved status.
Founder credentials (brand-stated). Statements about Dr. John Diaz's background speak to the founder, not to a guarantee about your individual treatment or outcome.
Buyer Takeaway: Marketing tells you how a brand wants to be seen. Policies, pricing pages, and provider and pharmacy details tell you what you're actually buying. Weight the second group more heavily.
Who RxSpan MD Is Built For (and Who Should Look Elsewhere)
This is where matching the right reader to the right product pays off, because RxSpan MD genuinely fits some people and genuinely doesn't fit others.
It may fit you if: you're an adult exploring physician-reviewed weight-loss options, you understand and accept the compounded-versus-approved distinction, you want bundled pricing and telehealth convenience, and you're comfortable doing the verification checks above. It probably isn't your match if: you specifically require an FDA-approved finished product, you have contraindications that make GLP-1 therapy inappropriate, you want in-person clinical care, or you're not comfortable with the 2026 regulatory uncertainty around compounded GLP-1.
Buyer Takeaway: The best outcome here is an honest match, not a sale at any cost. If the compounded model and the regulatory context don't sit right with you, that's useful information - and a provider may reach the same conclusion during review.
RxSpan MD Beyond Weight Loss: Longevity, Hair, and Additional Categories
RxSpan MD isn't only a GLP-1 platform; its source material lists additional categories, and it's worth knowing they exist even if weight loss is why you're here. Availability, eligibility, and prescription requirements may vary by product, state, and provider review.
The brand lists a longevity category (with products such as NAD+, sermorelin, and glutathione), a hair category (built around ingredients like minoxidil, finasteride, and dutasteride), and additional men's and women's telehealth categories. Many of these are compounded or specialty preparations carrying the same not-FDA-approved status as compounded GLP-1, and several peptide-type products in this space have drawn FDA attention - so the same verify-before-you-enroll discipline applies. Finasteride and dutasteride, for example, carry known potential side effects that a provider should review with you before prescribing.
This article makes no treatment or performance claims for any of these products. Review the risks, prescription requirements, and regulatory status of each one with a licensed healthcare provider. Whatever the category, the structure is the same: platform, independent licensed provider, licensed pharmacy, with prescription at provider discretion.
Buyer Takeaway: The breadth is a convenience if you want one platform for several needs. It's also a reminder to evaluate each product on its own regulatory and safety footing rather than assuming one approval status covers the whole catalog.
Meet the Founder: Dr. John Diaz (Brand-Stated Background)
Per RxSpan MD's published materials, Dr. John Diaz is described as the founder and a board-certified plastic surgeon with more than 20 years of experience, with degrees from Cornell University and the Albert Einstein College of Medicine, and various research and leadership honors the brand lists. This article has not independently audited each credential listed in the brand's materials.
Two honest notes. You may verify provider and founder credentials through relevant licensing and credentialing sources if those details affect your decision. And a founder's specialty isn't necessarily the specialty of the provider who reviews your specific intake - your prescribing clinician is part of the independent licensed provider group, which is the credential set most relevant to your care.
Buyer Takeaway: A credentialed founder is a positive signal, not a substitute for confirming that the provider who actually reviews your case is licensed in your state and appropriate for GLP-1 care.
Safety, Side Effects, and Questions to Ask Your Provider
This section is general education only and is not a substitute for professional medical advice. Only a licensed healthcare provider can determine whether GLP-1 treatment is appropriate for you.
GLP-1 medications come with a real side-effect and safety profile that belongs in your provider conversation. Commonly reported side effects in this class include nausea, vomiting, diarrhea, constipation, and injection-site reactions. More serious risks discussed in class labeling include pancreatitis and gallbladder problems, and the approved products carry contraindications related to a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Ask your provider how to measure, administer, store, and titrate any injectable medication before use. This matters especially for compounded injectable GLP-1 products, where the FDA has reported dosing-error concerns. This article doesn't tell you to start, stop, adjust, or dose any medication - those are decisions for you and your provider.
Buyer Takeaway: Bring two questions to your consultation: am I a safe candidate given my history, and exactly how do I dose and store this. If you can't get clear answers to both, don't start.
Telehealth, Privacy, and Your Health Data at RxSpan MD
Telehealth means your health information moves through digital channels, so it's worth knowing how it's handled. RxSpan MD publishes a Notice of Privacy Practices and a Telehealth Medical Consent, and per those documents the company describes itself as maintaining the privacy and security of Protected Health Information and outlines your rights to access your records, request corrections, request confidential communications, and request restrictions on certain disclosures.
Before you enroll, read the Privacy Notice and the telehealth consent form, and ask any data-specific questions you have - how your information is stored, who it's shared with for treatment and payment, and how to exercise your access and correction rights. The consent materials also describe general telehealth risks, including technical failures or incomplete information through electronic communication.
Buyer Takeaway: Your health data is part of what you're handing over. Read the privacy and consent documents the way you'd read a contract - because that's what they are - and ask before you sign rather than after.
RxSpan MD Subscriptions, Billing, and How to Cancel
RxSpan MD's plans are subscription-style: pre-paid monthly or quarterly, with multi-month tiers that lower the per-month price. That's convenient, and it also means you're authorizing recurring or prepaid billing, so the cancellation mechanics matter.
The brand states you can cancel or change plans at any time. To protect yourself, confirm the exact cancellation method, any deadline relative to your billing cycle, and how renewals work before you enroll - and keep a written record. If you need to cancel, the published contact channels are [email protected] and 844-357-3601 (text or call). Subscription and auto-renewal programs are subject to consumer-protection rules at the federal and state level, including expectations around clear, easy cancellation, so a smooth process is reasonable to expect.
Buyer Takeaway: Screenshot the cancellation terms before you pay. The time to understand how you get out is before you're in, not after a renewal you didn't expect.
The RxSpan MD Refund Cliff: What Can Become Non-Refundable, and When
Quick Answer: In telehealth programs like RxSpan MD, the most important refund question is timing - what's refundable before a prescription is written versus after. Because you pay before the provider review, confirm in writing, before you enroll, what becomes non-refundable once a prescription is issued or medication is prepared.
This is the single costliest thing buyers overlook in the GLP-1 telehealth category, so it's worth slowing down on. You pay first, then a licensed provider reviews your intake. If you're approved and the pharmacy prepares your medication, the economics change, because compounded, patient-specific preparations are often non-returnable once made, which is standard across the category for safety reasons. That's not unique to RxSpan MD, and it isn't a knock on the brand; it's the nature of dispensed prescription medication.
What it means for you: read RxSpan MD's published refund and cancellation terms and confirm, in writing through the support channels, exactly where the non-refundable line sits. Ask specifically what happens if a provider declines to prescribe after you've paid. A clear answer protects you; a vague one is a reason to pause before enrolling.
Buyer Takeaway: The refund cliff is a timing question, not a fine-print footnote. Pin down the exact moment your money stops being refundable before you pay, not after.
Shipping, Support, and What's Included
Per the brand, the plan price bundles consultation, medication, supplies, and shipping, and RxSpan MD advertises free, expedited delivery and around-the-clock support with unlimited messaging and appointments. For injectable GLP-1, "supplies" generally means the materials needed for a weekly self-administered subcutaneous injection; confirm exactly what arrives in your kit so you're not missing anything on day one. Because compounded injectable medications can be temperature-sensitive, it's also worth confirming shipping and storage handling.
Support quality is hard to verify before you buy, so treat the 24/7 claim as a positioning statement and test it early - send a question through the support channel before you commit, and see how the response lands.
Buyer Takeaway: "Everything included" is a genuine convenience if it holds. Confirm what's in the box, how it ships, and how support responds before your billing cycle locks in.
RxSpan MD vs. Other GLP-1 Telehealth Platforms (Category Comparison)
RxSpan MD operates in a crowded field of compounded-GLP-1 telehealth platforms, and naming that openly is more useful to you than pretending it's alone. The comparison points that actually separate these platforms aren't logos; they're the things you can verify.
When you compare RxSpan MD to alternatives, line them up on: all-in monthly price for the same medication and dose, which licensed pharmacy fills the prescription and under which pathway, refund terms before and after prescription, cancellation ease, provider licensing in your state, and how transparently each one handles the 2026 regulatory picture. A platform that discloses its pharmacy, its refund cliff, and the compounding-rule context is giving you more to work with than one that leads with a low headline price and goes quiet on specifics. These comparisons reference competitors by category position only, for your context - not as criticism of any named operator.
Buyer Takeaway: Don't compare on headline price alone. Two programs at the same monthly number can be very different once you account for refunds, pharmacy, and provider licensing.
What Consumers Should Verify Before Enrollment
Run this sequence before you complete enrollment. Each item takes minutes and can save you real money and hassle.
The 5 things to verify before enrolling in RxSpan MD:
Confirm the all-in price for your specific medication and dose at checkout.
Confirm the provider is licensed in your state and identify the provider group.
Confirm the dispensing pharmacy and its compounding pathway.
Confirm the refund cliff - what becomes non-refundable once a prescription is written.
Confirm the cancellation method and billing cycle before you authorize payment.
The expanded checklist below covers the full set.
Current all-in pricing for your specific medication and dose, including anything calculated at checkout
Billing cycle - monthly versus prepaid quarter or longer, and when it renews
Refund terms - what becomes non-refundable once a prescription is written
Cancellation method and timing
Provider licensing in your state
Dispensing pharmacy and its compounding pathway
Whether compounded or brand-name medication is being considered
Whether a prescription is clinically appropriate for you
Dosing and storage instructions
Shipping temperature handling for any temperature-sensitive product
Current FDA and state-law context for compounded GLP-1
Privacy and data handling
Emergency-care instructions - know when to seek in-person or emergency care
Buyer Takeaway: If a program makes any of these hard to answer, that friction is your answer. A confident, compliant operation can clear this list without flinching.
View current RxSpan MD plan information on the official page
RxSpan MD Frequently Asked Questions
What is RxSpan MD and who operates it?
RxSpan MD is a direct-to-consumer telehealth platform operated by RxSpan MD LLC, headquartered at 465 N Roxbury Drive, Penthouse Suite, Beverly Hills, CA 90210. According to its published Terms, it connects adults with independent licensed healthcare providers for prescription treatment across weight loss, longevity, and hair categories. The platform's Terms place medical-care responsibility with the licensed providers, and medications, if prescribed, may be fulfilled by licensed pharmacies. You can reach the company at [email protected] or 844-357-3601.
Does RxSpan MD prescribe the medication itself?
According to the brand's Terms of Service, healthcare providers using the platform are independent medical professionals responsible for the medical care they provide, and a prescription is only issued if a provider determines treatment is clinically appropriate. The brand's checkout language states that a provider reviews your information after checkout and that prescription is not guaranteed. Consumers should confirm the specific provider group and state licensing directly with RxSpan MD. This separation between platform, provider, and pharmacy is standard structure in compliant telehealth.
How much does RxSpan MD cost?
Per the brand's published pricing reviewed for this article, compounded semaglutide injection is listed from $249 for the first month and compounded tirzepatide injection from $329, with prescription approval not guaranteed after provider review. Plan tiers lower the per-month cost over longer commitments: $249 monthly, $219 on three months, $199 on six months, and $194 on twelve months. The brand states the price includes consultation, medication, supplies, shipping, and support. Brand-name options like Ozempic, Wegovy, and Zepbound are referenced at substantially higher prices. Confirm your all-in total at checkout.
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Ozempic® and Wegovy® are FDA-approved finished semaglutide products made by Novo Nordisk. Compounded semaglutide is prepared by a pharmacy and is not an FDA-approved finished drug product, meaning it hasn't been reviewed by FDA for safety, effectiveness, or quality before marketing. They share the active-ingredient family but differ in regulatory status, price, and oversight. Consumers interested in FDA-approved finished products should discuss brand-name options with a licensed healthcare provider.
Is compounded GLP-1 still available in 2026?
The picture has tightened. The FDA resolved the semaglutide and tirzepatide shortages in 2025, ending the broad shortage-based pathway that powered large-scale compounding, and in April 2026 proposed excluding these drugs from the 503B bulks list, with a comment period through June 29, 2026. Patient-specific compounding by state-licensed pharmacies (the 503A pathway) remains under narrow, individualized conditions. Because availability can change, confirm directly that any program sources from a properly licensed pharmacy operating within current rules.
Is RxSpan MD legit?
RxSpan MD publishes a real operating entity, a physical address, working contact channels, and full policy documents, which are markers of an identifiable, legitimate operation. Whether it's the right fit is something you verify across specific dimensions: provider licensing in your state, which pharmacy dispenses, all-in pricing, refund and cancellation terms, and data privacy. The brand gives you enough published information to run those checks. Treat any verification badge as something to confirm at its source rather than accept on sight.
Will I definitely get a prescription if I pay?
No. Payment does not guarantee a prescription. After checkout, an independent licensed provider reviews your intake and decides whether treatment is clinically appropriate. If it isn't, you won't be prescribed the medication. Because you pay before that review, the refund policy - specifically what's refundable before versus after a prescription is written - is one of the most important terms to confirm in writing before you enroll.
How do I cancel an RxSpan MD plan?
The brand states you can cancel or change plans at any time. To protect yourself, confirm the exact cancellation method and any timing relative to your billing cycle before you enroll, and keep a written copy of those terms. The published contact channels for support and cancellation are [email protected] and 844-357-3601 (text or call). Subscription programs are subject to consumer-protection rules around clear and easy cancellation, so a smooth process is reasonable to expect.
What are the side effects of GLP-1 medications?
Commonly reported side effects in this class include nausea, vomiting, diarrhea, constipation, and injection-site reactions. More serious risks discussed in class labeling include pancreatitis and gallbladder issues, and the approved products carry contraindications related to a personal or family history of medullary thyroid carcinoma or MEN 2. For compounded products, the FDA has flagged dosing-error risk. This is general educational information; only a licensed healthcare provider can determine whether GLP-1 treatment is appropriate for you.
Does RxSpan MD offer anything besides weight loss?
Yes. Alongside GLP-1 weight loss, RxSpan MD's source material lists longevity products (such as NAD+, sermorelin, and glutathione) and hair products (built around ingredients like minoxidil, finasteride, and dutasteride), plus additional men's and women's telehealth categories. Many are compounded or specialty preparations carrying the same not-FDA-approved status as compounded GLP-1. Availability, eligibility, and prescription requirements may vary by product, state, and provider review, so evaluate each one with a licensed healthcare provider.
How does RxSpan MD handle my health data?
RxSpan MD publishes a Notice of Privacy Practices and a Telehealth Medical Consent describing how Protected Health Information is used and your rights to access records, request corrections, request confidential communications, and request restrictions. Before enrolling, read both documents and ask any data-specific questions - how information is stored, who it's shared with for treatment and payment, and how to exercise your rights. Telehealth also carries general risks like technical failures or incomplete information through electronic communication.
Who is Dr. John Diaz?
Per RxSpan MD's published materials, Dr. John Diaz is described as the founder and a board-certified plastic surgeon with more than 20 years of experience, with degrees from Cornell University and the Albert Einstein College of Medicine and various honors. These are brand-stated credentials you can confirm through public credentialing sources if they matter to you. This article hasn't independently audited each one. Note that the founder's specialty isn't necessarily the specialty of the provider who reviews your intake, so confirm your prescribing clinician's licensing as well.
Where does RxSpan MD ship and what's included?
The brand advertises free, expedited delivery and states the plan price includes consultation, medication, supplies, and shipping, with around-the-clock support and unlimited messaging and appointments. For injectable GLP-1, supplies generally cover what's needed for weekly self-administered subcutaneous injection. Confirm exactly what arrives in your kit, the delivery timeline, and temperature handling before your billing cycle locks in, and consider testing the support channel with a question before you commit.
What's the difference between the monthly and multi-month plans?
The difference is per-month price versus commitment length. The monthly plan is a brand-stated $249 per month with no long commitment; the three-, six-, and twelve-month plans drop the per-month price to $219, $199, and $194 respectively, in exchange for prepaying a longer term. Longer plans save money if you stay the course, but they also mean more is prepaid up front, so weigh the savings against the cancellation and refund terms before choosing a longer commitment.
Should I choose RxSpan MD over a brand-name prescription from my own doctor?
That depends on your priorities and eligibility, and it's a personal decision. RxSpan MD offers convenience, bundled pricing, and lower-cost compounded options; an in-person doctor and an FDA-approved finished product offer different assurances and often higher cost. Neither is universally right. If you have a physician relationship and insurance coverage for brand-name GLP-1, compare that path. If cost and access are barriers and you accept the compounded trade-offs, a telehealth route may fit. A provider's review is part of either path.
Is compounded semaglutide legal in 2026?
Compounded semaglutide is not FDA-approved, and its availability narrowed in 2025 and 2026. The broad, shortage-based compounding pathway ended after the FDA resolved the semaglutide and tirzepatide shortages, and in April 2026 the FDA proposed excluding these drugs from the 503B outsourcing-facility bulks list, with a comment period through June 29, 2026. Patient-specific compounding by state-licensed pharmacies (the 503A pathway) remains under narrow, individualized conditions. Because the picture can change, confirm that any program sources from a properly licensed pharmacy operating within current rules.
Can you get a GLP-1 prescription through telehealth without a medical evaluation?
No. Through a platform like RxSpan MD, a prescription requires review by an independent licensed healthcare provider, and approval is not guaranteed. Per the brand's Terms, providers make clinical decisions and determine whether treatment is appropriate after reviewing your information. Paying for a plan is not the same as receiving a prescription. Any service implying you can get prescription GLP-1 with no clinical evaluation at all would be a reason for serious caution, not a convenience.
How much does compounded tirzepatide cost without insurance at RxSpan MD?
RxSpan MD lists compounded tirzepatide injection from a brand-stated $329 for the first month, with plan tiers that lower the per-month cost over longer commitments. This is a self-pay, cash price, and the platform's model doesn't rely on insurance. By comparison, the brand references FDA-approved brand-name options at roughly $1,069 and up per month. Confirm the current all-in total and any dose-based differences at checkout before paying, since pricing can change.
Is RxSpan MD a scam?
RxSpan MD publishes an identifiable operating entity, a physical Beverly Hills address, working contact channels, and complete policy documents, which are markers of a real, identifiable operation rather than an anonymous one. Whether it's right for you is a separate question you answer by verifying provider licensing in your state, the dispensing pharmacy, all-in pricing, refund and cancellation terms, and data privacy. Use the verification framework in this article rather than relying on a star rating, and confirm any third-party badge at its source.
What happens to my RxSpan MD plan if compounded GLP-1 rules tighten further?
That's exactly the question to ask the program directly before enrolling. Because the FDA has signaled a tightening direction for compounded semaglutide and tirzepatide, a well-run platform should be able to explain how it would handle further restrictions, whether through 503A patient-specific compounding, a transition to brand-name options, or another route. There's no universal answer, so confirm RxSpan MD's specific approach through its support channels, and weigh it alongside the refund and cancellation terms.
How fast does RxSpan MD ship, and what is included?
RxSpan MD advertises free, expedited delivery and states the plan price includes consultation, medication, supplies, shipping, and support. Exact timelines depend on provider approval and pharmacy processing, so confirm the current shipping window and what arrives in your kit before your billing cycle locks in. Because compounded injectables can be temperature-sensitive, it's also worth confirming how the medication is packaged and shipped.
What This Article Does Not Claim
This article does not claim that RxSpan MD guarantees prescription approval, guarantees weight loss, provides FDA-approved compounded medications, operates as a pharmacy, replaces in-person medical care, or is appropriate for every consumer. This article does not independently test RxSpan MD products or services, verify individual pharmacy operations, or provide medical, legal, or regulatory advice. Consumers should rely on licensed healthcare providers and the official RxSpan MD website for current treatment, eligibility, and pricing information.
Final Analysis: Is RxSpan MD the Right Fit for You?
RxSpan MD is an identifiable, policy-complete telehealth platform offering compounded and brand-name GLP-1 weight-loss options through a standard three-party structure, with bundled pricing that starts well below brand-name cost. Its strengths are pricing transparency, category breadth, and a clearly separated platform-provider-pharmacy model. The honest cautions apply to the whole compounded-GLP-1 category in 2026: the products aren't FDA-approved, the regulatory environment is tightening, and the refund and cancellation terms deserve careful reading before you pay.
If you've read this far, you already know the move - verify the handful of things that matter to you, talk to the provider about safety and dosing, and make the call with full information. That's how you turn an ad you clicked into a decision you actually own.
View the current RxSpan MD offer and availability.
Buyer Takeaway: The strongest position you can be in is informed and unhurried. RxSpan MD gives you the published information to verify; the regulatory context gives you a reason to verify now rather than later.
Important Disclosures
FDA Disclaimer. These statements have not been evaluated by the Food and Drug Administration. The products and services referenced are not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Prescription medication is available only after consultation and approval by a licensed healthcare provider, if clinically appropriate, and approval is not guaranteed. This article is for general educational purposes and is not a substitute for professional medical advice; always consult a qualified healthcare provider regarding any medical condition or treatment.
Affiliate Disclosure. This article contains affiliate links. A commission may be earned on qualifying purchases made through links in this content, at no additional cost to the reader. Affiliate relationships do not influence editorial content or the evaluation of products. Disclosure is provided in accordance with FTC 16 CFR Part 255.
Material Limitations of This Review. This article is based exclusively on publicly available materials, including the official RxSpan MD website, the brand's published Terms of Service, Notice of Privacy Practices, and Telehealth Medical Consent, and category-level guidance on telehealth and compounded GLP-1 medications. This publication has not received compensated product samples for testing, has not interviewed brand personnel, has not been granted access to internal specifications beyond what is publicly published, and has not conducted laboratory or clinical testing of any RxSpan MD product or service. Claims described as "according to the brand" or "brand-stated" reflect what the brand has publicly stated and have not been independently substantiated by this publication. Promotional language referenced in the title or body of this article - including but not limited to phrases such as "Physician-Guided" and "No Hidden Fees" - originates with the RxSpan MD brand's own published marketing materials and is identified in this article for reader-context purposes, not as independent endorsement or performance guarantee. Buyers are encouraged to verify any claim that materially affects their purchase decision by contacting the brand directly using the published support channels.
Third-Party Consumer Feedback Platforms. This article references the existence of third-party consumer feedback platforms in general category terms only. This publication does not endorse, vouch for, audit, or accept responsibility for the accuracy, completeness, or fairness of customer reviews posted on any third-party platform, including general-purpose review sites, social media platforms, and online discussion forums. Buyers consulting third-party reviews are encouraged to evaluate them critically, look for verified-purchase indicators where available, and weigh reviewer-specific context against their own situation.
Customer Feedback and Testimonials. Any customer ratings, testimonials, or outcome descriptions referenced in connection with the brand are brand-reported and have not been independently audited by this publication. Individual experiences vary, and experiences described by others do not predict your result.
Forward-Looking Statements and Article Accuracy. This article reflects information available as of June 2026 and was prepared using reasonable care to be accurate and useful at the time of publication. Product specifications, pricing, promotional offers, shipping policies, cancellation and refund terms, contact information, regulatory status, and customer feedback data may change after publication without notice. Statements describing expected buyer outcomes, performance expectations, or category trends are educational forward-looking observations, not guarantees. No representation is made that the information will remain accurate in the future, and no warranty of merchantability, fitness for a particular purpose, or non-infringement is provided in connection with the editorial content of this article. Readers should rely on the official RxSpan MD website as the authoritative source for current product information prior to any purchase decision.
Reasonable Consumer Standard. This article is written for a general adult consumer audience and intends statements to be interpreted as a reasonable consumer would interpret them in context. Where a statement could otherwise be read as a brand-substantiated fact, attribution language such as "according to the brand," "brand-stated," "brand-reported," or "per the official Terms" identifies it as a brand claim that has not been independently verified by this publication. Promotional superlatives and headline marketing phrases appearing on the brand's website - including, without limitation, "Physician-Guided," "No Hidden Fees," "Doctor-led Plans & Coaching," and "Quality is our guarantee" - are explicitly identified in this article (including in the dedicated "About the Promotional Language" and "How to Read RxSpan MD's Marketing Language" sections) as brand-asserted marketing language and are not represented as independent third-party rankings, performance guarantees, or laboratory-verified claims by this publication.
California Proposition 65. Residents of California should review product labeling and the manufacturer's published information for any applicable Proposition 65 warnings regarding exposure to chemicals known to the State of California to cause cancer or reproductive harm, and may contact the brand directly with questions.
Geographic and Jurisdiction Notice. Availability of telehealth services and prescription products varies by state and jurisdiction and is subject to applicable law and provider licensing. Services may not be available in all locations. Buyers outside the United States, including in the European Union and United Kingdom, should be aware that consumer-protection rules, pricing-display requirements, and distance-selling rights differ by jurisdiction, and that any "before" or comparison prices shown by the brand are the brand's own stated reference points and may not reflect prevailing market prices.
Trademark Acknowledgment. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. RxSpan MD and any associated logos are marks of their respective owner. All trademarks, product names, and brand names referenced in this article belong to their respective owners and are used for identification and nominative reference only. Their use does not imply affiliation with or endorsement by the trademark holders.
No Professional Relationship. This publication is not a healthcare provider, pharmacy, or licensed medical entity, and nothing in this article creates a doctor-patient, pharmacist-patient, or other professional relationship. Any clinical relationship is established solely between you and the independent licensed providers and pharmacies involved in your care.
Email: [email protected] | Phone: 844-357-3601
SOURCE: RxSpan MD